Guess for upcoming quarterly, page-35

That's not that bad. I'm around .088 now.

It would be worst if you bought in at IPO!

It wouldn't take long for this to switch around. People still comparing price to IPO level.

IPO level - Potential of FDA approval, solid cash in bank (off back of ipo), a couple different product options and relatively the same amount of clients.

Clients have come and gone since IPO.

Difference is now - FDA approval and EUA on two products (respectfully), larger integration/partnership with Hologic, reoccurring annual revenue of $10M services income and mind you, a number of these services were for manufacturing of product due for release now/this year and new products FFN to come about. So revenue has remained relatively steady since IPO at the end of the day.

Mind you if you look back at the original reporting at time of IPO to now:

All reporting at IPO was listed in AUD.

All reporting NOW is listed in USD. If people aren't paying attention to that, they would see circa $20M in revenues in 2021 and $10M in revenues in 2023. Its the same figure.

That could really be distorting those investors who don't truly complete due diligence deeply enough to realise. They may just be scanning and note a halvin of revenue which isn't actually correct.